Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
SYNERGY PHARMA (NQ: SGYP)
5.050 USD  UNCHANGED
Official Closing Price  /  Updated: 4:00 PM EDT, May 22, 2013  /  Add to My Watchlist      
View: Quote News
Press releases about SYNERGY PHARMA
 
< Previous 1 2 3 Next >
Synergy Pharmaceuticals Presents Plecanatide Results From a Large Multicenter Clinical Study at Late-Breaking Abstract Session During Digestive Disease Week 2013
May 21, 2013
from GlobeNewswire News Releases
Synergy Pharmaceuticals Added to NASDAQ Biotechnology Index
May 14, 2013
from GlobeNewswire News Releases
Semi-Annual Changes to the NASDAQ Biotechnology Index
May 13, 2013
from GlobeNewswire News Releases
Synergy Pharmaceuticals Reports First Quarter 2013 Financial Results
May 09, 2013
from GlobeNewswire News Releases
Synergy Pharmaceuticals' Chief Scientific Officer to Give Plenary Lecture on Plecanatide and SP-333 at the 15th Annual TIDES Summit
May 09, 2013
from GlobeNewswire News Releases
Synergy Pharmaceuticals Announces Closing of Public Offering of Shares of Common Stock
April 16, 2013
from GlobeNewswire News Releases
Squawk Box Stocks Reports on: Royale Energy Inc. (NASDAQ: ROYL), Star Scientific, Inc. (NASDAQ: STSI), Synergy Pharmaceuticals, Inc. (NASDAQ: SGYP), Health Management Associates Inc. (NYSE: HMA)
April 11, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Synergy Pharmaceuticals Inc. Announces Pricing of Public Offering of Common Stock
April 10, 2013
from GlobeNewswire News Releases
Free Research Reports on ECL, FOE, LDK and SGYP Issued by the Paragon Report
April 10, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Synergy Pharmaceuticals Inc. Announces Public Offering of Common Stock
April 09, 2013
from GlobeNewswire News Releases
Synergy Pharmaceuticals Reports 2012 Fourth Quarter and Full-Year Financial Results
March 18, 2013
from GlobeNewswire News Releases
Synergy Pharmaceuticals to Present Study Results From Plecanatide Phase IIb/III Trial in Late-Breaking Clinical Abstract at Digestive Disease Week 2013
March 15, 2013
from GlobeNewswire News Releases
Synergy Pharmaceuticals to Present at Two Upcoming Investor Conferences
February 22, 2013
from GlobeNewswire News Releases
Synergy Pharmaceuticals to Begin Trading on The NASDAQ Global Market
February 11, 2013
from GlobeNewswire News Releases
Synergy Pharmaceuticals to Present at Two Upcoming Investor Conferences
February 07, 2013
from GlobeNewswire News Releases
Synergy Pharmaceuticals Initiates Multiple Ascending Dose Phase Ib Trial in Healthy Volunteers of SP-333, a Second Generation Guanylate Cyclase C Agonist for the Treatment of Ulcerative Colitis
January 28, 2013
SP-333 Advances to Multiple-Dosing Safety Study Read More
from GlobeNewswire News Releases
Synergy Pharmaceuticals Announces Closing of Merger With Callisto Pharmaceuticals
January 17, 2013
from GlobeNewswire News Releases
Synergy Pharmaceuticals Announces Approval of Merger With Callisto Pharmaceuticals and Other Actions at Annual Meeting of Stockholders
January 15, 2013
from GlobeNewswire News Releases
Synergy Announces Adjournment of Annual Meeting
January 03, 2013
from GlobeNewswire News Releases
Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry's Success in 2012
January 03, 2013
Five Star Equities Provides Stock Research on Emergent Biosolutions and Synergy Pharmaceuticals Read More
from Marketwired News Releases
Perfect Trade Setups, How to Play SGYP, CLSP, VTUS and PGNX
January 03, 2013
from Marketwired News Releases
Free Research Reports on LPH, LRCX, SGYP and WYNN Issued by the Bedford Report
January 03, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Synergy Announces Positive Results From Plecanatide Phase IIb/III Trial in Patients With Chronic Idiopathic Constipation
January 02, 2013
from GlobeNewswire News Releases
Synergy Pharmaceuticals Completes Phase I Trial of SP-333, a Second-Generation GC-C Agonist to Treat Gastrointestinal Diseases
December 28, 2012
from GlobeNewswire News Releases
Synergy Pharmaceuticals Begins Phase IIb Trial of Plecanatide in Irritable Bowel Syndrome With Constipation (IBS-C)
December 27, 2012
from GlobeNewswire News Releases
Synergy Pharmaceuticals Presents Poster on Novel Mechanism of Action of SP-333, an Agonist of Guanylate Cyclase-C for Treatment of Ulcerative Colitis
December 14, 2012
Scientific Poster Presentation at 2012 Advances in IBD Conference Read More
from GlobeNewswire News Releases
VFC's Stock House Weekly Stock Watch, Week of 10 December
December 10, 2012
from EmailWire.Com Press Releases
VFC's Stock House Weekly Stock Watch, Week of 3 December
December 03, 2012
from EmailWire.Com Press Releases
VFC's Stock House Weekly Stock Watch, Week of 26 November
November 26, 2012
from EmailWire.Com Press Releases
Synergy Pharmaceuticals to Present at Piper Jaffray Healthcare Conference
November 21, 2012
from GlobeNewswire News Releases
< Previous 1 2 3 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here